Ozempic changed the game.
You did everything right.
You got the prescription. You lost the weight. The number on the scale finally moved in the direction you’d wanted for years — maybe decades.
And then the fear set in.
What happens when the medication stops? What happens when I can’t access it anymore? What happens if — no matter what I do — the weight comes back?
If you’ve asked yourself any of these questions, you are not being dramatic. You are being realistic. And the research backs you up.
Studies show that a significant proportion of individuals who lose weight on GLP-1 medications like Ozempic, Wegovy, and Mounjaro regain the majority of that weight within one to two years of stopping — because the medication addresses the biology of hunger and metabolism, but not the psychology that drives the behaviors behind weight gain.
That’s not a flaw in the medication. It’s a gap in how most people approach treatment.
This article is about that gap — what it contains, why it matters, and what evidence-based psychological support actually looks like for people navigating GLP-1-assisted weight loss.
GLP-1 medications work by mimicking a hormone that signals fullness, slows gastric emptying, and regulates blood sugar. For many people, the result is a dramatic reduction in appetite — including the constant food noise that has driven their relationship with eating for years.
This is, by nearly every account, a relief.
But it also removes something that has been functioning as a primary coping mechanism.
For many people — far more than typically get acknowledged — food has served as the primary tool for managing stress, anxiety, loneliness, boredom, grief, and emotional discomfort. When a GLP-1 medication suppresses appetite, it doesn’t just suppress hunger. It removes access to that coping mechanism.
And the underlying emotional drivers? They’re still there.
This is where the psychological work begins — and where most GLP-1 treatment plans stop.
Significant weight loss changes how you look, how others treat you, and — most disorienting — how you relate to your own body. Many people report that their self-image doesn’t update alongside the scale. They still move through the world with the psychological habits, assumptions, and self-narrative of a body they no longer inhabit.
This disconnect is real. It’s clinically recognized. And it doesn’t resolve itself without intentional psychological work.
The medication can suppress the biological drive to eat. It cannot change the learned association between food and emotional relief that has been reinforced over a lifetime.
When appetite suppression fades — whether due to dose changes, medication access issues, or eventual discontinuation — those patterns remain. Without alternative coping tools in place, the behavioral patterns that contributed to weight gain return.
Many people carry deeply internalized beliefs about body, worth, and self-discipline — beliefs shaped by a culture that has moralizes body size for decades. These narratives don’t disappear when the weight does. They frequently resurface as fear of regain, difficulty accepting the body at its new size, or a sense that success is fragile and temporary.
Unexamined, these beliefs are among the strongest predictors of weight regain.
There is significant cultural stigma — even among medication users themselves — around using pharmaceutical support for weight loss. Many people hold ambivalent feelings about the prescription: relief that it’s working, guilt that they “couldn’t do it on their own,” uncertainty about what it means for their identity and self-image.
These feelings rarely get examined. They don’t go away on their own. And they have real consequences for how people approach long-term maintenance.
Weight loss changes relationships. Some become stronger. Others become more complicated. New attention from people who treated you differently when your body looked different. Family dynamics that shifted when your relationship with food changed. Social rituals built around eating that now feel different.
None of this is covered in the prescription information.
The data here is not ambiguous.
A 2022 trial published in Diabetes, Obesity and Metabolism found that participants who stopped taking semaglutide (the active ingredient in Ozempic and Wegovy) regained approximately two-thirds of their prior weight loss within one year. A separate analysis found that without sustained behavioral and psychological support, weight regain following GLP-1 discontinuation is the norm — not the exception.
This isn’t a failure of willpower. It’s a predictable outcome when the biological intervention ends and nothing has changed in the psychological and behavioral architecture underneath.
GLP-1 medications are a powerful tool. They are not, by themselves, a complete treatment.
Relapse prevention for GLP-1-assisted weight loss isn’t about food rules or accountability check-ins. It’s about the psychological and behavioral work that makes change last.
Clinically, this includes:
Behavioral foundations that don’t depend on the prescription. Building genuine habits around movement, sleep, stress management, and nutrition that are integrated into your life — not dependent on continued appetite suppression.
Alternative coping strategies. Identifying the emotional functions that food has served and developing concrete, practiced alternatives — before the medication ends and the biological appetite returns.
Body image work. Processing the experience of significant weight change — the identity shift, the complicated emotions, the internal narrative that updates more slowly than the mirror.
Shame and worth examination. Addressing the internalized beliefs about body and self-discipline that drive the relapse cycle, rather than leaving them to operate below the surface.
Community with shared experience. The psychological experience of GLP-1-assisted weight loss is specific, recent, and often isolating. Processed in a group of people navigating the same territory — with clinical guidance — it becomes considerably less so.
If any of the following resonates, this kind of psychological support is worth considering:
This work doesn’t require you to be in crisis. It requires you to be honest about the fact that the prescription — as valuable as it is — is only part of what lasting change requires.
At TrueMe® Counseling, we run a clinically facilitated support group specifically designed for individuals using or transitioning off GLP-1 medications — focused on the psychological, emotional, and identity dimensions of weight loss that medication alone cannot reach.
The group is:
This is not a diet program. It is not a nutrition plan. It is the psychological work that determines whether GLP-1-assisted weight loss becomes a genuine, lasting transformation — or the beginning of another cycle.
Do I need to currently be on a GLP-1 medication or Ozempic to join?
No. The group is designed for individuals at every stage — beginning, mid-treatment, transitioning off, or maintaining results after discontinuation. The psychological work of sustainable weight management is relevant regardless of where you are in your medication timeline.
Is this an Ozempic diet program or nutrition service?
No. TrueMe® is a licensed clinical counseling practice. We do not prescribe medications, provide meal plans, or offer medical advice. We provide the psychological, emotional, and behavioral work that determines whether physical weight loss translates into lasting change.
What does “relapse prevention” actually mean here?
Relapse prevention refers to the psychological and behavioral work of reducing the risk of weight regain — particularly after GLP-1 treatment ends. This includes building alternative coping strategies, examining shame-based narratives, developing behavioral foundations independent of the medication, and processing the identity dimensions of significant weight change.
Is everything shared in the group confidential?
Yes. Confidentiality is foundational to the group’s clinical structure and to the safety required for this kind of work.
How do I get started?
Enrollment begins with a conversation — no obligation, no commitment. Group size is intentionally limited, so availability may be restricted. Call TrueMe® Counseling at (818) 964-1806 or reach out through the contact page. Inquiries are handled with discretion.
GLP-1 medications or Ozempic have changed the landscape of weight loss in ways that are genuinely significant. For many people, they have made possible what nothing else could.
But the prescription has a limit. It addresses the biology. It does not address the psychology — the beliefs, the behaviors, the coping patterns, the identity, the fear — that determine whether what the medication starts actually lasts.
That work is available. It is evidence-based. And it is exactly what TrueMe®’s GLP-1 group was built to provide.
You don’t have to figure this out alone.
→ Learn More About the GLP-1 Group at TrueMe® Counseling
→ Call Us: (818) 964-1806
